Jump to content
Sign in to follow this  

Xalt2 study (NSCLC/ALK+)

Recommended Posts



If you have non-small cell lung cancer (NSCLC) that is ALK positive, you may be interested in learning more about a clinical research study opportunity.


The Xalt2 study is being done to find out if an investigational medication is safe and how tumors respond to it in patients with NSCLC whose tumors test positive for the ALK gene.


You may be able to join the Xalt2 clinical research study if you:


·         Are 18 years of age or older

·         Have been diagnosed with ALK positive NSCLC

Study participants will receive the investigational medication in cycles of approximately 28 days each. Not all participants will be in the study for the same amount of time.


To learn more: www.MyXalt2Study.com


Share this post

Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
Sign in to follow this